The Cancer Drug Development Forum – CDDF is the platform for all stakeholders involved in the development of cancer drugs.

Latest News and Resources from CDDF


FDA issues Draft Guidance on MRD Testing.

Davy Chiodin, one of our programme committee members for the MRD multi-stakeholder workshop, said “The Cancer Drug Development Forum aims to help paint a realistic picture of what’s really needed from all parties for robust and global MRD validation plans.” Read the article


CDDF is launching a new initiative on Microbiomes!
Read more and join the first workshop in February 2019


Support the ECPC Personalised Medicine Awareness Month #PMAM18
This November, join the European Cancer Patient Coalition (ECPC) advocating for greater access to molecular testing in Europe. Just one test could change a patient’s treatment plan & help us in #CrackingTheCancerCode. Show your support for ECPC Personalised Medicine Awareness Month: #PMAM18


Read the discussion summary of the CDDF Multi-stakeholder workshop on Involving Patients In Oncology Drug Development (18-19 June 2019, Amsterdam)

The use of real-world data in cancer drug development
European Journal of Cancer (EJC), Volume 101, September 2018, Pages 69-76

The Current and Future Challenges of Personalised Cancer Therapy published in the Open Access Government Magazine: ‘Managing Director of The Cancer Drug Development Forum, Prof. H. Zwierzina reveals his opinions on the current and future challenges of personalised cancer therapy, including the need for biomarkers’

5th Immunotherapy of Cancer Conference (ITOC5), 19-21 March 2018, Berlin, Germany – Abstract Book
European Journal of Cancer (EJC), Volume 92, Supplement 1, S1-S26, March 2018

Read the summary of the CDDF 10th Alpine Conference
(26 – 28 February 2018, Innsbruck, Austria)

More CDDF publications? Click here !


twitter32x32Follow us on Twitter! cddf_eu
Follow the latest updates and join the discussion by using #cddf





Cancer Drug Development Forum
c/o BLSI
Clos Chapelle-aux-Champs 30
1200 Brussels, Belgium
Tel: +32 2 880 62 70

Legal address
c/o Deloitte Tirol
Wirtschaftsprüfungs GmbH,
Wilhelm-Greil-Str. 15,
6020 Innsbruck, Austria